PIK3C2G Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-25052
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody has been engineered to specifically recognize the recombinant protein PIK3C2G using the following amino acid sequence: PNPNESHEKQYEHQEFLFVNQPHSSSQVSLGFDQIVDEISGKIPHYESEIDENTFFVPTAPKWDSTGHSLNEAHQISLNEFTSKSRELSWHQ
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for PIK3C2G Antibody
Immunocytochemistry/Immunofluorescence: PIK3C2G Antibody [NBP3-25052]
Staining of human cell line GAMG shows localization to plasma membrane.Applications for PIK3C2G Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 µg/ml
Application Notes
For ICC/IF, we recommend using a combination of PFA and Triton X-100. This will give you the optimal results for your experiments.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: PIK3C2G
Long Name
Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma
Alternate Names
PI3K-C2-gamma
Gene Symbol
PIK3C2G
Additional PIK3C2G Products
Product Documents for PIK3C2G Antibody
Product Specific Notices for PIK3C2G Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...